Product Information
QC HEADACHE 250-250-65 MG TAB is a generic product labeled by Chain Drug Marketing Association, priced at $0.0672 per EA under NDC 83324006324. Its NADAC has been published 44 times since Jul 30, 2025.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen, Aspirin, Caffeine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250; 250; 65 mg/1; mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324006324
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
ACETAMINOPHEN; ASPIRIN; CAFFEINEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
6/19/2025
Pharmacological Classes
Price Statistics
The NADAC for QC HEADACHE 250-250-65 MG TAB has been published 44 times since Jul 30, 2025, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0672 per EA |
|---|---|
| All-time high | $0.0691 (Oct 15, 2025) |
| All-time low | $0.0635 (Jan 21, 2026) |
| 52-week high | $0.0691 |
| 52-week low | $0.0635 |
| Median price | $0.0658 |
| Average price | $0.0662 |
| Largest weekly change | +4.7% (Aug 20, 2025) |
| Weeks tracked | 44 |
| Tracking since | Jul 30, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC HEADACHE 250-250-65 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QC HEADACHE 250-250-65 MG TAB, manufactured by Chain Drug Marketing Association, is $0.0672 per EA (NDC 83324006324), effective May 27, 2026.
How has the price of QC HEADACHE 250-250-65 MG TAB changed over time?
Over the history we have for it, the NADAC for QC HEADACHE 250-250-65 MG TAB has risen 2.5%. It has been tracked across 44 weekly CMS publications since Jul 30, 2025.
What are the highest and lowest recorded NADAC prices for QC HEADACHE 250-250-65 MG TAB?
Since Jul 30, 2025, the NADAC for QC HEADACHE 250-250-65 MG TAB has ranged from a low of $0.0635 (Jan 21, 2026) to a high of $0.0691 (Oct 15, 2025), with a median of $0.0658 per EA.
Are there cheaper alternatives to QC HEADACHE 250-250-65 MG TAB?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MIGRAINE 250-250-65 MG CPLT, is $0.0663 per EA — about 1% below QC HEADACHE 250-250-65 MG TAB.
Who manufactures QC HEADACHE 250-250-65 MG TAB?
QC HEADACHE 250-250-65 MG TAB (NDC 83324006324) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification